Cronos Group (CRON) Posts Double-Digit Cannabis Growth and Expands International Footprint

We recently published 12 Best Healthcare Stocks to Buy Under $30. Cronos Group Inc. (NASDAQ:CRON) is one of the best healthcare stocks.

Cronos Group Inc. (NASDAQ:CRON) is a global cannabis company operating primarily in Canada and Israel, with recognized brands like PEACE NATURALS and Spinach. The company focuses on both medicinal and recreational cannabis markets and is expanding internationally into Australia, Malta, Germany, and Switzerland.

In Q2 2025, Cronos Group Inc. (NASDAQ:CRON) reported a 21% year-over-year revenue increase to $33.5 million, driven mainly by its PEACE NATURALS brand in Israel and other international markets. Despite a net loss of $38.5 million influenced partly by foreign exchange impacts, the consolidation of its Canadian cultivation subsidiary, Cronos GrowCo, contributed $2.2 million in flower sales and helped boost gross margins from 23% to 43%.

The business strategically focuses on global markets like Israel to offset U.S. regulatory uncertainties and recently resolved an anti-dumping dispute there, stabilizing its international operations. The corporation maintains a strong liquidity position with $834 million in cash and short-term investments, supporting initiatives like an $18.5 million convertible loan investment in Canadian retailer High Tide Inc.

Looking ahead, analysts expect profitability to improve with a 50% capacity increase at GrowCo, supporting rising demand and better margins. Q3 2025 revenue is forecasted at $37.3 million with adjusted EBITDA rising to $5.6 million, reflecting operational momentum. Additionally, Cronos Group Inc. (NASDAQ:CRON) announced a $50 million share repurchase program, signaling confidence in its growth prospects.

While we acknowledge the potential of CRON as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.